940. The use of a commercially available CMV T Cell Immunity Panel to Assess the Risk of CMV Infections in Hematopoietic Cell Transplant Recipients with Low Level CMV Viremia

BACKGROUND: Cytomegalovirus (CMV) infections continue to be associated with increased morbidity and mortality in Hematopoietic Cell Transplant (HCT) recipients. Treatment of high risk patients with low level viremia may reduce overall duration of therapy and reduce complications. CMV T Cell Immunity...

Descripción completa

Detalles Bibliográficos
Autores principales: Khawaja, Fareed, Sadaka, Carmen, Trager, Samantha, Fernandes, Kerri E, Angelidakis, Georgios, Heredia, Ella Ariza, Altrich, Michelle, Chemaly, Roy F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644686/
http://dx.doi.org/10.1093/ofid/ofab466.1135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644686/
http://dx.doi.org/10.1093/ofid/ofab466.1135

Ejemplares similares